Life Science Trend Analysis 2015 for Austria
With three rounds of financing and a combined value of USD 6.7M, 2014 proved to be a weak year for biotech financing in Austria. 2015 is set to look very different, as Austrian biotech financing gains momentum with an impressive USD 50M financing round to Nabriva to start off the first half of 2015.
Looking for your next Biotech or Medtech partner?
Use Biotechgate to identify new leads, licensing opportunities and management details.